Accessibility Menu

Zhengye Biotechnology

(NASDAQ) ZYBT

Current Price$0.83
Market Cap$25.04M
Since IPO (2025)-83%
5 YearN/A
1 Year-88%
1 Month-12%

Zhengye Biotechnology Financials at a Glance

Market Cap

$25.04M

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-$0.21

P/E Ratio

-4.10

Dividend

$0.00

Beta (Volatility)

1.56 (High)

Price

$0.83

Volume

64

Open

$0.84

Previous Close

$0.83

Daily Range

$0.83 - $0.84

52-Week Range

$0.68 - $13.08

Estimated Earnings Date

N/A

ZYBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zhengye Biotechnology

Industry

Pharmaceuticals

Sector

Health Care

Employees

269

CEO

Aiden Han; Song Lin Song

Website

www.jlzybio.com

Headquarters

Jilin, 132101, CN

ZYBT Financials

Key Financial Metrics (TTM)

Gross Margin

21%

Operating Margin

-59%

Net Income Margin

-60%

Return on Equity

-26%

Return on Capital

-22%

Return on Assets

-16%

Earnings Yield

-24.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.04M

Shares Outstanding

29.73M

Volume

64

Avg. Volume

276.97K

Financials (TTM)

Gross Profit

CN¥23.87M

Operating Income

-CN¥68.25M

EBITDA

-CN¥42.52M

Operating Cash Flow

CN¥13.33M

Capital Expenditure

-CN¥12.63M

Free Cash Flow

CN¥703.00K

Cash & ST Invst.

CN¥51.89M

Total Debt

CN¥75.08M

Zhengye Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$25.04M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATOSAtossa Therapeutics, Inc.
$2.22-5.53%
IXHLIncannex Healthcare Limited
$3.73+1.63%
TILInstil Bio, Inc.
$7.61-3.91%
EXOZeXoZymes, Inc.
$7.42+0.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$201.80+0.05%
AALAmerican Airlines Group
$15.71+0.02%
NOKNokia
$13.98-0.06%
SOFISoFi Technologies
$17.71+0.03%

Questions About ZYBT

What is the current price of Zhengye Biotechnology?

Zhengye Biotechnology is trading at $0.83 per share.

What is the 52-week range for Zhengye Biotechnology?

Over the past 52 weeks, Zhengye Biotechnology has traded between $0.68 and $13.08.

How much debt does Zhengye Biotechnology have?

As of the most recent reporting period, Zhengye Biotechnology reported total debt of CN¥10.74M.

How much cash does Zhengye Biotechnology have on hand?

Zhengye Biotechnology reported CN¥7.20M in cash and cash equivalents in its most recent financial results.

What is Zhengye Biotechnology’s dividend yield?

Zhengye Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services